Description
Selank is a heptapeptide developed at the Institute of Molecular Genetics, Russian Academy of Sciences. It is studied for anxiolytic effects and its influence on enkephalin metabolism and BDNF expression.
For laboratory research use only. Not for human or veterinary use, not a drug, food or cosmetic. Sold to qualified researchers.
Reviews
There are no reviews yet.